Syncom Formulations (India) Limited a publié ses résultats financiers pour le deuxième trimestre et les six premiers mois de l'exercice clos le 30 septembre 2025. Au titre du deuxième trimestre, la ...

Syncom Formulations (India) Limited, a leading name in the Indian pharmaceutical sector specialising in high-quality pharmaceutical formulations, has announced an outstanding performance for the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

China's commerce ministry said on Saturday it hopes the United States will provide an open, fair and non-discriminatory business environment for Chinese companies to continue operating in the U.S., ...

MUMBAI, Feb 15 (Reuters) - Syncom Formulations India Ltd board on Friday approved issue of 310,000 shares at 46 rupees a share to the founders of the company. The board also approved issue of 325,000 ...